Xinlan Lu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 5
-
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Co-authors
- Mudan Ren (23 shared papers)Shuixiang He (15 shared papers)Yarui Li (13 shared papers)Yan Zhao (13 shared papers)Guifang Lu (10 shared papers)Guifang Lu (12 shared papers)Dan Guo (5 shared papers)Dan Zhang (8 shared papers)
- Journals
- Oncology Reports (3 papers)Scandinavian Journal of Gastroenterology (2 papers)Cell Death and Disease (2 papers)Journal of Gastroenterology and Hepatology (2 papers)Digestive Diseases and Sciences (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Xinlan Lu
41 papers receiving 910 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 278
- Hepatology 110
- Complementary and alternative medicine 72
- Oncology 76
- Molecular Biology 207
Countries citing papers authored by Xinlan Lu
This map shows the geographic impact of Xinlan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinlan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinlan Lu more than expected).
Fields of papers citing papers by Xinlan Lu
This network shows the impact of papers produced by Xinlan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinlan Lu. The network helps show where Xinlan Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinlan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 111 | |
| 2 | 2019 | 70 | |
| 3 | 2016 | 56 | |
| 4 | 2012 | 55 | |
| 5 | 2019 | 50 | |
| 6 | 2016 | 46 | |
| 7 | 2020 | 43 | |
| 8 | 2017 | 41 | |
| 9 | 2014 | 35 | |
| 10 | 2015 | 34 | |
| 11 | 2018 | 31 | |
| 12 | 2020 | 30 | |
| 13 | 2018 | 29 | |
| 14 | 2018 | 26 | |
| 15 | 2020 | 26 | |
| 16 | 2018 | 24 | |
| 17 | 2020 | 20 | |
| 18 | 2013 | 19 | |
| 19 | 2022 | 19 | |
| 20 | 2014 | 17 |
About Xinlan Lu
Xinlan Lu is a scholar working on Cancer Research, Hepatology, Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, having authored 42 papers that have together received 929 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Gastric Cancer Management and Outcomes (6 papers), Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (5 papers), Ubiquitin and proteasome pathways (3 papers), Cell death mechanisms and regulation (3 papers), Innovative Microfluidic and Catalytic Techniques Innovation (3 papers) and Colorectal Cancer Surgical Treatments (2 papers). The work is most often cited by research in Cancer Research (278 citations), Hepatology (110 citations), Complementary and alternative medicine (72 citations), Oncology (76 citations) and Molecular Biology (207 citations). Xinlan Lu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Mudan Ren, Shuixiang He, Yarui Li, Yan Zhao, Guifang Lu, Guifang Lu, Dan Guo, Dan Zhang, Shuixiang He and Yanan Hu. Their work appears in journals such as Oncology Reports, Scandinavian Journal of Gastroenterology, Cell Death and Disease, Journal of Gastroenterology and Hepatology and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.